Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part II): In Silico Prediction in Antidiabetic Extracts

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Guasch, Laura ^a   Sala, Esther ^a   Ojeda, María José ^a   Valls, Cristina ^a   Bladé, Cinta ^a   Mulero, Miquel ^a   Blay, Mayte ^a   Ardévol, Anna ^a   Garcia Vallvé, Santiago ^a,b   Pujadas, Gerard ^a,b  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b TECNIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AJMALINE; ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; EPHEDRINE; EPIGALLOCATECHIN GALLATE; HALOSALINE; HYDROXYSMIRNOVINE; ISOCHANOCLAVIN; ISOSANDWICHINE; N NORORIENTALINE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PROCYANIDIN DERIVATIVE; PSEUDOEPHEDRINE; SERPININE; TECOSTAMINE; UNCLASSIFIED DRUG; BIOLOGICAL PRODUCT; DIPEPTIDYL PEPTIDASE IV;

ACONITE; ACONITUM JAPONICUM; ANTIDIABETIC ACTIVITY; ARTICLE; COMPUTER ANALYSIS; DIABETES MELLITUS; DRUG EFFICACY; DRUG SCREENING; ENZYME INHIBITION; ERVATAMIA OFFICINALIS; MEDICINAL PLANT; PREDICTION; SOLANUM; SOLANUM NUDUM; SOLANUM SODOMAEUM; STEPHANIA; STEPHANIA CEPHARANTHA; STRUCTURAL HOMOLOGY; STRUCTURE ACTIVITY RELATION; TABERNAEMONTANA; TABERNAEMONTANA EGLANDULOSA; VIRTUAL REALITY; BIOLOGY; COMPUTER INTERFACE; HUMAN; METABOLISM;

BIOLOGICAL AGENTS; COMPUTATIONAL BIOLOGY; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DRUG EVALUATION, PRECLINICAL; HUMANS; HYPOGLYCEMIC AGENTS; PLANT EXTRACTS; USER-COMPUTER INTERFACE;

EID: 84866678743     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044972     Document Type: Article

References (79)

1. Guasch L, Ojeda MJ, González-Abuín N, Sala E, Ceretó A, et al. (2012) Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): Virtual screening and activity assays.
2. Howes M, Simmonds M (2005) Plants used in the treatment of diabetes. In: Soumyanath A, editor. Traditional Medicines for Modern Times. Press.
3. Yin J, Zhang H, Ye J, (2008) Traditional chinese medicine in treatment of metabolic syndrome. Endocr Metab Immune Disord Drug Targets 8(2): 99-111.
4. Modak M, Dixit P, Londhe J, Ghaskadbi S, Paul A Devasagayam T, (2007) Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 40(3): 163-173.
5. Andrade-Cetto Adolfo, Heinrich M, (2005) Mexican plants with hypoglycaemic effect used in the treatment of diabetes. J Ethnopharmacol 99(3): 325-348.
6. Haque N, Salma U, Nurunnabi T, Uddin M, Jahangir M, et al. (2011) Management of type 2 diabetes mellitus by lifestyle, diet and medicinal plants. Pak J Biol Sci 14(1): 13-24.
7. Malviya N, Jain S, Malviya S, (2010) Antidiabetic potential of medicinal plants. Acta Pol Pharm 67(2): 113-118.
8. Prabhakar PK, Doble M, (2008) A target based therapeutic approach towards diabetes mellitus using medicinal plants. Curr Diabetes Rev 4(4): 291-308.
9. Qi L, Liu E, Chu C, Peng Y, Cai H, et al. (2010) Anti-diabetic agents from natural products-an update from 2004 to 2009. Curr Top Med Chem 10(4): 434-457.
10. Bnouham M, Ziyyat A, Mekhfi H, Tahri A, Legssyer A (2006) Medicinal plants with potential antidiabetic activity- A review of ten years of herbal medicine research (1990-2000). Int J Diabetes Metab 14(1).
11. Prabhakar PK, Doble M, (2011) Mechanism of action of natural products used in the treatment of diabetes mellitus. Chin J Integr Med 17(8): 563-574.
12. Havale SH, Pal M, (2009) Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes. Bioorg Med Chem 17(5): 1783-1802.
13. Mentlein R, Gallwitz B, Schmidt W, (1993) Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 214(3): 829-835.
14. Brubaker PL, Drucker DJ, (2004) Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145(6): 2653-2659.
15. Meier JJ, Nauck MA, Schmidt WE, Gallwitz B, (2002) Gastric inhibitory polypeptide: The neglected incretin revisited. Regul Pept 107(1-3): 1-13.
16. Kim D, Wang L, Beconi M, Eiermann GJ, Fisher MH, et al. (2005) (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(24,5-trifluorophenyl)butan-2-amine: A potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J Med Chem 48(1): 141-151.
17. Villhauer EB, Brinkman JA, Naderi GB, Burkey BF, Dunning BE, et al. (2003) 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties. J Med Chem 46(13): 2774-2789.
18. Augeri DJ, Robl JA, Betebenner DA, Magnin DR, Khanna A, et al. (2005) Discovery and preclinical profile of saxagliptin (BMS-477118): A highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J Med Chem 48(15): 5025-5037.
19. Zettl H, Schubert-Zsilavecz Manfred, Steinhilber D, (2010) Medicinal chemistry of incretin mimetics and DPP-4 inhibitors. ChemMedChem 5(2): 179-185.
20. Kuhn B, Hennig M, Mattei P, (2007) Molecular recognition of ligands in dipeptidyl peptidase IV. Current Topics in Medicinal Chemistry 7(6): 609-619.
21. Sala E, Guasch L, Iwaszkiewicz J, Mulero M, Salvado M, et al. (2011) Identification of human IKK-2 inhibitors of natural origin (part I): Modeling of the IKK-2 kinase domain, virtual screening and activity assays. PloS One 6(2): e16903.
22. Ito K, Haruna M, Furukawa H, (1975) [Studies on the erythrina alkaloids. X. alkaloids of several erythrina plants from singapore]. Yakugaku Zasshi 95(3): 358-362.
23. Kumar A, Lingadurai S, Shrivastava TP, Bhattacharya S, Haldar PK, (2011) Hypoglycemic activity of erythrina variegata leaf in streptozotocin-induced diabetic rats. Pharm Biol 49(6): 577-582.
24. Oh WK, Lee CH, Seo JH, Chung MY, Cui L, et al. (2009) Diacylglycerol acyltransferase-inhibitory compounds from erythrina senegalensis. Arch Pharm Res 32(1): 43-47.
25. Bae EY, Na M, Njamen D, Mbafor JT, Fomum ZT, et al. (2006) Inhibition of protein tyrosine phosphatase 1B by prenylated isoflavonoids isolated from the stem bark of erythrina addisoniae. Planta Med 72(10): 945-948.
26. Na M, Jang J, Njamen D, Mbafor JT, Fomum ZT, et al. (2006) Protein tyrosine phosphatase-1B inhibitory activity of isoprenylated flavonoids isolated from erythrina mildbraedii. J Nat Prod 69(11): 1572-1576.
27. Nguyen P, Nguyen T, Dao T, Kang H, Ndinteh D, et al. (2010) AMP-activated protein kinase (AMPK) activation by benzofurans and coumestans isolated from erythrina abyssinica. J Nat Prod 73(4): 598-602.
28. Hammouda Y, Rashid K, Amer S, (1964) Hypoglycaemic properties of tecomine and tecostamine. J Pharm Pharmacol 16: 833-834.
29. Aguilar-Santamaria L, Ramirez G, Nicasio P, Alegria-Reyes C, Herrera-Arellano A, (2009) Antidiabetic activities of tecoma stans (L.) juss. ex kunth. J Ethnopharmacol 124(2): 284-288.
30. Ly TT, Hewitt J, Davey RJ, Lim EM, Davis EA, et al. (2011) Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes. Diabetes Care 34(1): 50.
31. Latha M, Pari L, Sitasawad S, Bhonde R, (2004) Scoparia dulcis, a traditional antidiabetic plant, protects against streptozotocin induced oxidative stress and apoptosis in vitro and in vivo. J Biochem Mol Toxicol 18(5): 261-272.
32. Nath CM, Chakrabority KM, Brahmachari DH, (1945) Investigations on the new antidiabetic principle (amellin); its role in the reduction of acetone bodies and the increase of alkali reserve of the blood of diabetics. Ann Biochem Exp Med 5(3): 101-104.
33. Konno C, Mizuno T, Hikino H, (1985) Isolation and hypoglycemic activity of ephedrans A, B, C, D and E, glycans of ephedra distachya herbs. Planta Med (2): 162-163.
34. Black OF, Kelly JW, (1927) Pseudo ephedrine from Ephedra alata. Amer. Jour. Pharm. 99: 748-751.
35. Grue-Sorensen G, Spenser ID, (1989) The biosynthesis of ephedrine. Can J Chem 67: 998-1009.
36. Osadchii SA, Shults EE, Polukhina EV, Shakirov MM, Vasilevskii SF, et al. (2007) Study of alkaloids of the siberian and altai flora 14. synthesis of alkaloid-based tertiary N-(3-arylprop-2-ynyl)amines. Russian Chemical Bulletin 56(6): 1261-1267.
37. Gilg E, Schürholf P (1930) Die ephedrinhaltigen stammpflanzen der "ma-huang"-droge. Arch Pharm (Weinheim) 233-239.
38. Shabana MM, Mirhom YW, Genenah AA, Aboutabl EA, Amer HA, (1990) Study into wild egyptian plants of potential medicinal activity. ninth communication: Hypoglycaemic activity of some selected plants in normal fasting and alloxanised rats. Arch Exp Veterinarmed 44(3): 389-394.
39. Campbell J, Mortensen A, Molgaard P, (2006) Tissue lipid lowering-effect of a traditional nigerian anti-diabetic infusion of rauwolfia vomitoria foilage and citrus aurantium fruit. J Ethnopharmacol 104(3): 379-386.
40. Benzi G, Villa R, Dossena M, Vercesi L, Gorini A, et al. (1984) Cerebral and cerebellar metabolic changes induced by drugs during the recovery period after profound hypoglycemia. Farmaco Sci 39(1): 44-56.
41. Gosh BP, (1958) Isolation of serpine and ajmaline from the root of rouvolfia Canescens. Naturwissenschaften 45(15): 365.
42. Gorman M, Neuss N, Djerassi C, Kutney JP, Scheuer PJ, (1957) Alkaloid studies-XIX: Alkaloids of some hawaiian rauwolfia species: The structure of sandwicine and its interconversion with ajmaline and ajmalidine. Tetrahedron 1(4): 328-337.
43. Chatterjee A, Talapatra S, (1955) Alkaloids of the roots of rauwolfia densiflora benth. and hook,rauwolfia perakensis King and gamble, rauwolfia canescens Linn. and rauwolfia serpentina benth. Naturwissenschaften 77: 3551-3553.
44. Hochstein F, Murai K, Boegemann W, (1955) Alkaloids of rauwolfia heterophylla. J Am Chem Soc 77(13): 3551-3554.
45. Roland M, (1959) [The alkaloids of rouwolfia obscura K. schum]. J Pharm Belg 14: 347-364.
46. Sheludko Y, Gerasimenko I, Kolshorn H, Stackigt J, (2002) New alkaloids of the sarpagine group from rauvolfia serpentina hairy root culture. J Nat Prod 65(7): 1006-1010.
47. van de Venter M, Roux S, Bungu LC, Louw J, Crouch NR, et al. (2008) Antidiabetic screening and scoring of 11 plants traditionally used in south africa. J Ethnopharmacol 119(1): 81-86.
48. Pinent M, Blay M, Bladé MC, Salvadó MJ, Arola L, et al. (2004) Grape seed-derived procyanidins have an antihyperglycemic effect in streptozotocin-induced diabetic rats and insulinomimetic activity in insulin-sensitive cell lines. Endocrinology 145(11): 4985-4990.
49. Montagut G, Onnockx S, Vaque M, Blade C, Blay M, et al. (2010) Oligomers of grape-seed procyanidin extract activate the insulin receptor and key targets of the insulin signaling pathway differently from insulin. J Nutr Biochem 21(6): 476-481.
50. Song E, Hur H, Han M, (2003) Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice. Arch Pharm Res 26(7): 559-563.
51. Fu Z, Zhen W, Yuskavage J, Liu D, (2011) Epigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice. Br J Nutr 105(8): 1218-1225.
52. Benn MH, Shustov G, Shustova L, Majak W, Bai Y, et al. (1996) Isolation and characterization of two guanidines from galega orientalis lam. cv. gale (fodder galega). J Agric Food Chem 44(9): 2779-2781.
53. Michel K, Sandberg F, Haglid F, Norin T, (1967) Alkaloids of haloxylon salicornicum (moq.-tand.) boiss. Acta Pharm Suec 4(2): 97-116.
54. Brack A, (1962) Verlauf der Alkaloidbildung durch den Clavicepsstamm von Pennisetum typhoideum Rich. in saprophytischer Kultur. 54. Mitteilung über Mutterkornalkaloide. Arch Pharm Pharm Med Chem 295(7): 510-515.
55. Fujii M, Takei I, Umezawa K, (2009) Antidiabetic effect of orally administered conophylline-containing plant extract on streptozotocin-treated and goto-kakizaki rats. Biomed Pharmacother 63(10): 710-716.
56. Yoshikawa M, Nakamura S, Ozaki K, Kumahara A, Morikawa T, et al. (2007) Structures of steroidal alkaloid oligoglycosides, robeneosides A and B, and antidiabetogenic constituents from the brazilian medicinal plant solanum lycocarpum. J Nat Prod 70(2): 210-214.
57. Villaseñor I, Lamadrid M, (2006) Comparative anti-hyperglycemic potentials of medicinal plants. J Ethnopharmacol 104(1-2): 129-131.
58. Kar DM, Maharana L, Pattnaik S, Dash GK, (2006) Studies on hypoglycaemic activity of solanum xanthocarpum schrad. & wendl. fruit extract in rats. J Ethnopharmacol 108(2): 251-256.
59. Mosihuzzaman M, Nahar N, Ali L, Rokeya B, Khan AK, et al. (1994) Hypoglycemic effects of three plants from eastern himalayan belt. Diabetes Res 26(3): 127-138.
60. Semwal DK, Rawat U, Semwal R, Singh R, Singh GJP, (2010) Anti-hyperglycemic effect of 11-hydroxypalmatine, a palmatine derivative from stephania glabra tubers. J Asian Nat Prod Res 12(2): 99-105.
61. Tsutsumi T, Kobayashi S, Liu YY, Kontani H, (2003) Anti-hyperglycemic effect of fangchinoline isolated from stephania tetrandra radix in streptozotocin-diabetic mice. Biol Pharm Bull 26(3): 313-317.
62. Dixon SL, Smondyrev AM, Knoll EH, Rao SN, Shaw DE, et al. (2006) PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. methodology and preliminary results. J Comput Aided Mol Des 20(10-11): 647-671.
63. Zsoldos Z, Reid D, Simon A, Sadjad SB, Johnson AP, (2007) eHiTS: A new fast, exhaustive flexible ligand docking system. J Mol Graph Model 26(1): 198-212.
64. Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK (2007) BindingDB: A web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res 35(Database issue): D198-201.
65. Duan J, Dixon SL, Lowrie JF, Sherman W, (2010) Analysis and comparison of 2D fingerprints: Insights into database screening performance using eight fingerprint methods. J Mol Graph Model 29(2): 157-170.
66. Kelley LA, Gardner SP, Sutcliffe MJ, (1996) An automated approach for clustering an ensemble of NMR-derived protein structures into conformationally related subfamilies. Protein Eng 9(11): 1063-1065.
67. Vuksan V, Sievenpiper JL, (2005) Herbal remedies in the management of diabetes: Lessons learned from the study of ginseng. Nutr Metab Cardiovasc Dis 15(3): 149-160.
68. Shukla K, Narain JP, Puri P, Gupta A, Bijlani RL, et al. (1991) Glycaemic response to maize, bajra and barley. Indian J Physiol Pharmacol 35(4): 249-254.
69. Ronchetti F, Russo G, Bombardelli E, Bonati A, (1971) A new alkaloid from rauwolfia vomitoria. Phytochemistry 10(6): 1385.
70. Phan MG, Phan TS, Matsunami K, Otsuka H, (2006) Chemical and biological evaluation on scopadulane-type diterpenoids from scoparia dulcis of vietnamese origin. Chem Pharm Bull 54(4): 546-549.
71. Costantino L, Raimondi L, Pirisino R, Brunetti T, Pessotto P, et al. (2003) Isolation and pharmacological activities of the tecoma stans alkaloids. Farmaco 58(9): 781-785.
72. Torres JL, Bobet R, (2001) New flavanol derivatives from grape (vitis vinifera) byproducts. antioxidant Aminoethylthio Flavan-3-ol conjugates from a polymeric waste fraction used as a source of flavanols. J Agric Food Chem 49(10): 4627-4634.
73. Takayama H, Okazaki T, Yamaguchi K, Aimi N, Haginiwa J, et al. (1988) Structure of two new diterpene alkaloids, 3-epi-ignavinol and 2,3-dehydrodelcosine. Chem Pharm Bull (Tokyo) 36(8): 3210-3212.
74. Konno C, Murayama M, Sugiyama K, Arai M, Murakami M, et al. (1985) Isolation and hypoglycemic activity of aconitans A, B, C and D, glycans of aconitum carmichaeli roots. Planta Med (2): 160-161.
75. Zhang H, Wang X, Lin L, Ding J, Yue J, (2007) Indole alkaloids from three species of the ervatamia genus: E. officinalis, E. divaricata, and E. divaricata gouyahua. J Nat Prod 70(1): 54-59.
76. Usubillaga A, (1988) Solanudine, a steroidal alkaloid from solanum nudum. Phytochemistry 27(9): 3031.
77. El Sayed KA, Hamann MT, Abd El-Rahman HA, Zaghloul AM, (1998) New pyrrole alkaloids from solanum sodomaeum. J Nat Prod 61(6): 848-850.
78. Kashiwaba N, Morooka S, Ono M, Toda J, Suzuki H, et al. (1997) Alkaloidal constituents of the leaves of stephania cepharantha cultivated in japan: Structure of cephasugine, a new morphinane alkaloid. Chem Pharm Bull (Tokyo) 45(3): 545-548.
79. Beek TAV, Verpoorte R, Svendsen AB, (1984) Alkaloids of tabernaemontana eglandulosa. Tetrahedron 40(4): 737.